Movatec (Meloxicam)

Meloxicam, the active ingredient in Movatec, is a nonsteroidal anti‑inflammatory drug presented as an oral tablet for oral use. It reduces inflammation and pain in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain.

GNH USA supplies Movatec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that targets inflammatory joint and musculoskeletal disorders. - Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: alleviates chronic inflammation and joint swelling. - Ankylosing spondylitis: diminishes spinal pain and stiffness. - Acute musculoskeletal pain: provides rapid relief of pain and inflammation.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort such as dyspepsia or nausea. - Headache or dizziness. - Peripheral edema. - Elevated blood pressure. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events including myocardial infarction or stroke. - Hepatic enzyme elevation or liver injury. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or severe hypersensitivity reactions.

Before prescribing Meloxicam, clinicians should consider several safety aspects. - Renal Function Assessment: evaluate kidney function, especially in the elderly or those with pre‑existing renal disease. - Cardiovascular Monitoring: watch for hypertension or signs of thrombotic events. - Gastrointestinal Risk: avoid in patients with a history of peptic ulcer disease or GI bleeding. - Concomitant NSAID Use: limit or avoid combined use to reduce GI and renal toxicity. - Pregnancy and Lactation: use only if the potential benefit justifies the potential risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal function. - Lithium: elevated lithium serum levels. - Methotrexate: increased methotrexate toxicity.

Moderate Interactions (Monitor Closely):\n- Diuretics: possible reduction in renal clearance. - Beta‑blockers: may blunt antihypertensive effect. - SSRIs or SNRIs: additive risk of bleeding. - Corticosteroids: enhanced risk of GI ulceration. - Antihypertensives: monitor blood pressure response.